Azelis announces a significant pharma partnership with JH Nanhang (JHNH) across Europe, Russia, Turkey and North Africa for PVP.

22 October 2013

Today speciality chemical distributor Azelis, is delighted to announce that it has partnered with JH Nanhang (JHNH) and signed an exclusive agreement to supply their range of polyvinylpyrolidones (PVP), for all Pharma applications across Europe, Turkey, Russia, Tunisia, Morocco and Algeria.

JHNH is the leading PVP manufacturer in China with an annual production of 5000MT.  The company meets all international standards for quality and safety including cGMP, ISO 9001 and ISO 14001 certifications.  Their Pharma products, marketed under the trade name Povidone are fully qualified, conforming to USP/EP/JP with drug master files available.

This deal is seen as a very positive move from both sides. The two companies have a shared vision to drive market expansion and sustainable business development by providing high quality products, backed by responsive customer care.

Dr. Tan Tiow Lin General Manager, Global Sales and Marketing JHNH explains, “Azelis is recognised for dedicated sales, marketing, technical support and supply chain excellence in the pharmaceutical industry.  At JHNH, we look forward to working with the Azelis pharma team to provide in depth application insight to customers, helping to improve product performance and optimise cost effectiveness.”

Matthew Dickman, International Business Director Azelis Pharma adds, “Azelis is excited about this opportunity to help drive JHNH’ strategy to penetrate western markets.  I am certain that this agreement will strengthen both our businesses across Europe, Russia, Turkey and North Africa, whilst at the same time giving our customers access to all that this key Chinese manufacturer can offer.”

The Povidone pharmaceutical range is suitable for a wide variety of applications including binders and stabilisers for tablets, film formers and solubilisers for injection preparations, and disintegrants for tablets, capsules and granules.   To support their introduction, Azelis plans to provide prototype formulations and laboratory support, inviting customers for product training days and lab visits.

All products are covered by a confirmation letter of REACH pre-registration.